These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 21724696)
1. Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels. Myles A; Viswanath V; Singh YP; Aggarwal A J Rheumatol; 2011 Sep; 38(9):1994-9. PubMed ID: 21724696 [TBL] [Abstract][Full Text] [Related]
2. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12. Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248 [TBL] [Abstract][Full Text] [Related]
3. Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis. Viswanath V; Myles A; Dayal R; Aggarwal A J Rheumatol; 2011 Nov; 38(11):2482-7. PubMed ID: 21885500 [TBL] [Abstract][Full Text] [Related]
4. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis. Saxena N; Aggarwal A; Misra R J Rheumatol; 2005 Jul; 32(7):1349-53. PubMed ID: 15996076 [TBL] [Abstract][Full Text] [Related]
6. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease. Bae CB; Suh CH; An JM; Jung JY; Jeon JY; Nam JY; Kim HA J Rheumatol; 2014 Dec; 41(12):2403-8. PubMed ID: 25274901 [TBL] [Abstract][Full Text] [Related]
7. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483 [TBL] [Abstract][Full Text] [Related]
8. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus. Bobek D; Grčević D; Kovačić N; Lukić IK; Jelušić M Pediatr Rheumatol Online J; 2014; 12():50. PubMed ID: 25516724 [TBL] [Abstract][Full Text] [Related]
9. Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA). Aggarwal A; Agarwal S; Misra R Clin Exp Immunol; 2007 Jun; 148(3):515-9. PubMed ID: 17374135 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis. Chen YS; Yan W; Geczy CL; Brown MA; Thomas R Arthritis Res Ther; 2009; 11(2):R39. PubMed ID: 19284577 [TBL] [Abstract][Full Text] [Related]
11. Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels. Kim HS; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY Nephrology (Carlton); 2013 Dec; 18(12):777-82. PubMed ID: 24124651 [TBL] [Abstract][Full Text] [Related]
12. Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study. Peake NJ; Khawaja K; Myers A; Jones D; Cawston TE; Rowan AD; Foster HE Rheumatology (Oxford); 2005 Nov; 44(11):1383-9. PubMed ID: 16049050 [TBL] [Abstract][Full Text] [Related]
13. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Leach ST; Yang Z; Messina I; Song C; Geczy CL; Cunningham AM; Day AS Scand J Gastroenterol; 2007 Nov; 42(11):1321-31. PubMed ID: 17852869 [TBL] [Abstract][Full Text] [Related]
14. HLA-G and HLA-E in patients with juvenile idiopathic arthritis. Prigione I; Penco F; Martini A; Gattorno M; Pistoia V; Morandi F Rheumatology (Oxford); 2011 May; 50(5):966-72. PubMed ID: 21186170 [TBL] [Abstract][Full Text] [Related]
15. Tenascin-C Levels, A Toll-like Receptor 4 Ligand, in Enthesitis-related Arthritis Category of Juvenile Idiopathic Arthritis: A Cross-sectional and Longitudinal Study. Shukla A; Gaur P; Aggarwal A J Rheumatol; 2015 May; 42(5):891-6. PubMed ID: 25774061 [TBL] [Abstract][Full Text] [Related]
16. Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis. Lotito AP; Campa A; Silva CA; Kiss MH; Mello SB J Rheumatol; 2007 Apr; 34(4):823-30. PubMed ID: 17343316 [TBL] [Abstract][Full Text] [Related]
17. Th1 and Th17 Predominance in the Enthesitis-related Arthritis Form of Juvenile Idiopathic Arthritis. Mahendra A; Misra R; Aggarwal A J Rheumatol; 2009 Aug; 36(8):1730-6. PubMed ID: 19531753 [TBL] [Abstract][Full Text] [Related]
18. Serum S100A12 (EN-RAGE) levels in patients with decreased renal function and subclinical chronic inflammatory disease. Zakiyanov O; Kalousová M; Kříha V; Zima T; Tesař V Kidney Blood Press Res; 2011; 34(6):457-64. PubMed ID: 21822023 [TBL] [Abstract][Full Text] [Related]
19. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease. Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017 [TBL] [Abstract][Full Text] [Related]
20. Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis. Olivito B; Simonini G; Ciullini S; Moriondo M; Betti L; Gambineri E; Cantarini L; De Martino M; Azzari C; Cimaz R J Rheumatol; 2009 Sep; 36(9):2017-24. PubMed ID: 19648312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]